• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UNS
Click for more information
0.00% 0.5¢

UNILIFE CORPORATION - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
UNSTrading haltPRICE SENSITIVE29/06/12
UNSUnilife Signs Supply Contract for UnifillPRICE SENSITIVE19/06/12
UNSResponse to ASX Price QueryPRICE SENSITIVE14/06/12
UNSUnilife Corporation - Q3 Results (31.03.12)PRICE SENSITIVE27/04/12
UNSAppendix 4C - quarterlyPRICE SENSITIVE27/04/12
UNSHalf Yearly Report and AccountsPRICE SENSITIVE10/02/12
UNSUnilife - Q2 2012 ResultsPRICE SENSITIVE10/02/12
UNSAppendix 4C - quarterlyPRICE SENSITIVE31/01/12
UNSUnilife Signs Clinical Development AgreementPRICE SENSITIVE30/11/11
UNSUnilife - Completes US$35.9 Million RaisingPRICE SENSITIVE17/11/11
UNSTrading Halt and Capital Raising AnnouncementPRICE SENSITIVE16/11/11
UNSUnilife - Q1 2012 Earnings ReleasePRICE SENSITIVE10/11/11
UNSAppendix 4C - quarterlyPRICE SENSITIVE28/10/11
UNSUnilife Wins Supply ContractPRICE SENSITIVE06/10/11
UNSUnilife - Develops Auto-InfusorPRICE SENSITIVE13/09/11
UNSUnilife - Develops Proprietary Range of Auto-InjectorsPRICE SENSITIVE31/08/11
UNSUnilife - Q4 2011 Earnings ReleasePRICE SENSITIVE31/08/11
UNSPreliminary Final Report - Appendix 4EPRICE SENSITIVE31/08/11
UNSUnilife Develops Unifill EZMix Prefilled SyringePRICE SENSITIVE24/08/11
UNSUnilife Signs Equipment Financing AgreementPRICE SENSITIVE16/08/11
UNSAppendix 4C - quarterlyPRICE SENSITIVE29/07/11
UNSUnilife Starts Unifill Syringe Sales to US Based Pharma CoPRICE SENSITIVE20/07/11
UNSUnilife Commences Initial Supply to SanofiPRICE SENSITIVE14/07/11
UNSUnilife Completes Industrialization of Unifill SyringePRICE SENSITIVE29/06/11
UNSUnilife Device Selected for Clinical TrialsPRICE SENSITIVE07/06/11
UNSUnilife 3Q ResultsPRICE SENSITIVE17/05/11
UNSAppendix 4C - quarterlyPRICE SENSITIVE29/04/11
UNSUnilife - Business RealignmentPRICE SENSITIVE06/04/11
UNSUnilife - Unifill Syringe Production UpdatePRICE SENSITIVE15/03/11
UNSAppendix 4D and Unilife 10-Q Second Quarter ResultsPRICE SENSITIVE15/02/11
UNSAppendix 4C - quarterlyPRICE SENSITIVE31/01/11
UNSUnilife Receives SPP Applications Exceeding A$12.8mPRICE SENSITIVE31/12/10
UNSUnilife - SPP Offer DocumentsPRICE SENSITIVE07/12/10
UNSUnilife Announces A$23.1m Placement and SPP OfferPRICE SENSITIVE29/11/10
UNSTrading HaltPRICE SENSITIVE25/11/10
UNSUnilife Q1 Conference CallPRICE SENSITIVE16/11/10
UNSUnilife Commences U.S. Sales of 1mL SyringesPRICE SENSITIVE15/11/10
UNSAppendix 4C - quarterlyPRICE SENSITIVE29/10/10
UNSUnilife Secures US Government Financial BackingPRICE SENSITIVE21/10/10
UNSUnilife - Unitract TB FDA ClearancePRICE SENSITIVE02/09/10
UNSPreliminary Final ReportPRICE SENSITIVE31/08/10
UNSResponse to ASX Price QueryPRICE SENSITIVE25/08/10
UNSUnilife - 8-K ReleasePRICE SENSITIVE20/08/10
UNSAppendix 4C - quarterlyPRICE SENSITIVE30/07/10
UNSResponse to ASX Price and Volume QueryPRICE SENSITIVE28/06/10
UNSAppendix 4C - quarterlyPRICE SENSITIVE30/04/10
UNSUnilife Enters Indian Healthcare MarketPRICE SENSITIVE30/04/10
UNSUnilife - FDA Approval for Unitract US SyringesPRICE SENSITIVE06/04/10
UNSHalf Year Accounts - US GAAPPRICE SENSITIVE24/03/10
UNSUnilife and Stason Sign Asian Sales Agreement for 1mlPRICE SENSITIVE10/03/10
UNSUnilife and sanofi-aventis Agree Exclusivity ListPRICE SENSITIVE03/03/10
UNSAppendix 4C - QuarterlyPRICE SENSITIVE29/01/10
UNSAdmission to Official ListPRICE SENSITIVE15/01/10
UNSTrading halt
29/06/12PRICE SENSITIVE
UNSUnilife Signs Supply Contract for Unifill
19/06/12PRICE SENSITIVE
UNSResponse to ASX Price Query
14/06/12PRICE SENSITIVE
UNSUnilife Corporation - Q3 Results (31.03.12)
27/04/12PRICE SENSITIVE
UNSAppendix 4C - quarterly
27/04/12PRICE SENSITIVE
UNSHalf Yearly Report and Accounts
10/02/12PRICE SENSITIVE
UNSUnilife - Q2 2012 Results
10/02/12PRICE SENSITIVE
UNSAppendix 4C - quarterly
31/01/12PRICE SENSITIVE
UNSUnilife Signs Clinical Development Agreement
30/11/11PRICE SENSITIVE
UNSUnilife - Completes US$35.9 Million Raising
17/11/11PRICE SENSITIVE
UNSTrading Halt and Capital Raising Announcement
16/11/11PRICE SENSITIVE
UNSUnilife - Q1 2012 Earnings Release
10/11/11PRICE SENSITIVE
UNSAppendix 4C - quarterly
28/10/11PRICE SENSITIVE
UNSUnilife Wins Supply Contract
06/10/11PRICE SENSITIVE
UNSUnilife - Develops Auto-Infusor
13/09/11PRICE SENSITIVE
UNSUnilife - Develops Proprietary Range of Auto-Injectors
31/08/11PRICE SENSITIVE
UNSUnilife - Q4 2011 Earnings Release
31/08/11PRICE SENSITIVE
UNSPreliminary Final Report - Appendix 4E
31/08/11PRICE SENSITIVE
UNSUnilife Develops Unifill EZMix Prefilled Syringe
24/08/11PRICE SENSITIVE
UNSUnilife Signs Equipment Financing Agreement
16/08/11PRICE SENSITIVE
UNSAppendix 4C - quarterly
29/07/11PRICE SENSITIVE
UNSUnilife Starts Unifill Syringe Sales to US Based Pharma Co
20/07/11PRICE SENSITIVE
UNSUnilife Commences Initial Supply to Sanofi
14/07/11PRICE SENSITIVE
UNSUnilife Completes Industrialization of Unifill Syringe
29/06/11PRICE SENSITIVE
UNSUnilife Device Selected for Clinical Trials
07/06/11PRICE SENSITIVE
UNSUnilife 3Q Results
17/05/11PRICE SENSITIVE
UNSAppendix 4C - quarterly
29/04/11PRICE SENSITIVE
UNSUnilife - Business Realignment
06/04/11PRICE SENSITIVE
UNSUnilife - Unifill Syringe Production Update
15/03/11PRICE SENSITIVE
UNSAppendix 4D and Unilife 10-Q Second Quarter Results
15/02/11PRICE SENSITIVE
UNSAppendix 4C - quarterly
31/01/11PRICE SENSITIVE
UNSUnilife Receives SPP Applications Exceeding A$12.8m
31/12/10PRICE SENSITIVE
UNSUnilife - SPP Offer Documents
07/12/10PRICE SENSITIVE
UNSUnilife Announces A$23.1m Placement and SPP Offer
29/11/10PRICE SENSITIVE
UNSTrading Halt
25/11/10PRICE SENSITIVE
UNSUnilife Q1 Conference Call
16/11/10PRICE SENSITIVE
UNSUnilife Commences U.S. Sales of 1mL Syringes
15/11/10PRICE SENSITIVE
UNSAppendix 4C - quarterly
29/10/10PRICE SENSITIVE
UNSUnilife Secures US Government Financial Backing
21/10/10PRICE SENSITIVE
UNSUnilife - Unitract TB FDA Clearance
02/09/10PRICE SENSITIVE
UNSPreliminary Final Report
31/08/10PRICE SENSITIVE
UNSResponse to ASX Price Query
25/08/10PRICE SENSITIVE
UNSUnilife - 8-K Release
20/08/10PRICE SENSITIVE
UNSAppendix 4C - quarterly
30/07/10PRICE SENSITIVE
UNSResponse to ASX Price and Volume Query
28/06/10PRICE SENSITIVE
UNSAppendix 4C - quarterly
30/04/10PRICE SENSITIVE
UNSUnilife Enters Indian Healthcare Market
30/04/10PRICE SENSITIVE
UNSUnilife - FDA Approval for Unitract US Syringes
06/04/10PRICE SENSITIVE
UNSHalf Year Accounts - US GAAP
24/03/10PRICE SENSITIVE
UNSUnilife and Stason Sign Asian Sales Agreement for 1ml
10/03/10PRICE SENSITIVE
UNSUnilife and sanofi-aventis Agree Exclusivity List
03/03/10PRICE SENSITIVE
UNSAppendix 4C - Quarterly
29/01/10PRICE SENSITIVE
UNSAdmission to Official List
15/01/10PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.